BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22018245)

  • 1. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
    Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
    Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.
    Tanaka R; Takahashi Y; Kodama A; Saito M; Ansari AA; Tanaka Y
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1147-54. PubMed ID: 20854204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses.
    Brice GT; Mayne AE; Villinger F; Ansari AA
    J Acquir Immune Defic Syndr; 2000 May; 24(1):10-22. PubMed ID: 10877490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
    Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
    Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.
    Montefiori DC; Collman RG; Fouts TR; Zhou JY; Bilska M; Hoxie JA; Moore JP; Bolognesi DP
    J Virol; 1998 Mar; 72(3):1886-93. PubMed ID: 9499040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells.
    Secchiero P; Zella D; Curreli S; Mirandola P; Capitani S; Gallo RC; Zauli G
    J Immunol; 2000 Apr; 164(8):4018-24. PubMed ID: 10754293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
    J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.
    Moody MA; Liao HX; Alam SM; Scearce RM; Plonk MK; Kozink DM; Drinker MS; Zhang R; Xia SM; Sutherland LL; Tomaras GD; Giles IP; Kappes JC; Ochsenbauer-Jambor C; Edmonds TG; Soares M; Barbero G; Forthal DN; Landucci G; Chang C; King SW; Kavlie A; Denny TN; Hwang KK; Chen PP; Thorpe PE; Montefiori DC; Haynes BF
    J Exp Med; 2010 Apr; 207(4):763-76. PubMed ID: 20368576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.
    Tanaka R; Yoshida A; Murakami T; Baba E; Lichtenfeld J; Omori T; Kimura T; Tsurutani N; Fujii N; Wang ZX; Peiper SC; Yamamoto N; Tanaka Y
    J Virol; 2001 Dec; 75(23):11534-43. PubMed ID: 11689635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
    Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
    J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity.
    Meta A; Torigoe N; Ito Y; Arakaki R; Nakashima H; Sugimura K
    Mol Immunol; 1999 Dec; 36(18):1249-54. PubMed ID: 10684964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis.
    Lin CL; Sewell AK; Gao GF; Whelan KT; Phillips RE; Austyn JM
    J Exp Med; 2000 Aug; 192(4):587-94. PubMed ID: 10952729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.